14-day Premium Trial Subscription Sign Up For FreeGet Free

Cyclacel Pharmaceuticals Stock Forecast NASDAQ:CYCC

Price Target and Analyst Ratings

Most Recent Rating

Oppenheimer is very positive about CYCC and gave it a "Outperform" rating on May 05, 2021. The price target was set to $17.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-05 Outperform Initiated by Oppenheimer $6.81 $17.00
2021-04-29 Outperform Initiated by Oppenheimer $7.11 $17.00
2021-04-29 Outperform Initiated by Oppenheimer $7.11
2020-05-21 Buy Reiterated by LADENBURG THALM/SH SH $5.17 $18.00
2020-05-21 Buy Reiterated by Roth Capital $5.17 $24.00
2020-05-19 Buy Initiated by Brookline Capital Management $4.37 $22.00

CYCC Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -9.24% during the next 3 months and, with a 90% probability hold a price between $3.94 and $5.38 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-22 $4.33 $5.12 $5.91
2021-09-23 $4.32 $5.11 $5.91
2021-09-24 $4.31 $5.10 $5.90
2021-09-27 $4.30 $5.09 $5.89
2021-09-28 $4.29 $5.08 $5.88
2021-09-29 $4.28 $5.07 $5.87
2021-09-30 $4.27 $5.06 $5.86
2021-10-01 $4.26 $5.06 $5.85
2021-10-04 $4.25 $5.05 $5.84
2021-10-05 $4.24 $5.04 $5.83
2021-10-06 $4.23 $5.03 $5.82
2021-10-07 $4.22 $5.02 $5.81
2021-10-08 $4.21 $5.01 $5.80
2021-10-11 $4.20 $5.00 $5.79
2021-10-12 $4.20 $4.99 $5.78
2021-10-13 $4.19 $4.98 $5.77
2021-10-14 $4.18 $4.97 $5.76
2021-10-15 $4.17 $4.96 $5.75
2021-10-18 $4.16 $4.95 $5.74
2021-10-19 $4.15 $4.94 $5.73
2021-10-20 $4.14 $4.93 $5.72
2021-10-21 $4.13 $4.92 $5.71
2021-10-22 $4.12 $4.91 $5.70
2021-10-25 $4.11 $4.90 $5.69
2021-10-26 $4.10 $4.89 $5.68
2021-10-27 $4.09 $4.88 $5.68
2021-10-28 $4.08 $4.87 $5.67
2021-10-29 $4.07 $4.86 $5.66
2021-11-01 $4.06 $4.85 $5.65
2021-11-02 $4.05 $4.84 $5.64

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT